The management challenges of a case with Flupentixol‐induced neuroleptic malignant syndrome
Sign Up to like & getrecommendations! Published in 2022 at "Neuropsychopharmacology Reports"
DOI: 10.1002/npr2.12315
Abstract: Neuroleptic malignant syndrome (NMS) is a rare and life‐threatening reaction. The incidence rate of NMS has dropped because of the higher use of atypical antipsychotics, compared with the typical ones. The mortality rate in patients… read more here.
Keywords: neuroleptic malignant; case flupentixol; management challenges; flupentixol induced ... See more keywords
The neuroleptic malignant syndrome
Sign Up to like & getrecommendations! Published in 2018 at "Medicina Clinica"
DOI: 10.1007/978-3-642-83042-6_56
Abstract: Since the introduction of neuroleptics in the treatment of psychiatric disorders in the late 1950s, drug-induced extrapyramidal syndromes have been well documented [1]. Fatal hyperpyrexia during chlorpromazine therapy was first reported in 1956 [2] and… read more here.
Keywords: neuroleptic malignant; malignant syndrome;
Neuroleptic malignant syndrome: Case report and literature review
Sign Up to like & getrecommendations! Published in 2017 at "European Psychiatry"
DOI: 10.1016/j.eurpsy.2017.01.822
Abstract: Introduction Neuroleptic malignant syndrome (NMS) is an uncommon but potentially fatal adverse effect of neuroleptic, both classic and atypical drugs. Objective To review the incidence, clinical characteristics, diagnosis and treatment of NMS. Aim We have… read more here.
Keywords: neuroleptic malignant; treatment; malignant syndrome; syndrome case ... See more keywords
There is more to this fever than meets the eye: A case of neuroleptic malignant-like syndrome (NMLS) secondary to withdrawal of procyclidine and L-dopa on a background of long-standing flupenthixol depot use.
Sign Up to like & getrecommendations! Published in 2020 at "Irish journal of psychological medicine"
DOI: 10.1017/ipm.2020.14
Abstract: This case report highlights the risk of development of Neuroleptic Malignant-Like Syndrome secondary to withdrawal of procyclidine with brief withdrawal of L-dopa and long-term typical antipsychotic depot. The patient responded to reintroduction of procyclidine, sedation… read more here.
Keywords: neuroleptic malignant; case; procyclidine; withdrawal ... See more keywords
[Electroconvulsive Therapy (ECT) in Neuroleptic Malignant Syndrome (NMS) on an Intensive Care Unit (ICU)].
Sign Up to like & getrecommendations! Published in 2022 at "Psychiatrische Praxis"
DOI: 10.1055/a-1702-2345
Abstract: A 57-year-old female patient with unclear somnolence was admitted to an Intermediate Care Unit (IMC) by an emergency physician. Several psychotropic drugs were on the medication list (quetiapine 450 mg/d, paroxetine 40 mg/d and perphenazine 12 mg/d), due… read more here.
Keywords: intensive care; neuroleptic malignant; care unit; care ... See more keywords
S216. CASE REPORT OF TREATMENT OF NEUROLEPTIC MALIGNANT SYNDROME IN CHILD ADOLESCENT
Sign Up to like & getrecommendations! Published in 2020 at "Schizophrenia Bulletin"
DOI: 10.1093/schbul/sbaa031.282
Abstract: Abstract Background Neuroleptic Malignant Syndrome is a rare clinical syndrome occurring due to idiosyncratic reaction after use of neuroleptics. We report a case of neuroleptic malignant syndrome in an adolescent patient with schizophrenia after treatment… read more here.
Keywords: neuroleptic malignant; treatment; case; report ... See more keywords
A Validation Study of the International Consensus Diagnostic Criteria for Neuroleptic Malignant Syndrome
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Psychopharmacology"
DOI: 10.1097/jcp.0000000000000640
Abstract: Background Neuroleptic malignant syndrome requires prompt recognition for effective management, but there are no established diagnostic criteria. This is the first validation study of recently published international expert consensus (IEC) diagnostic criteria, which include priority… read more here.
Keywords: neuroleptic malignant; dsm; validation study; diagnostic criteria ... See more keywords
A Mixed Presentation of Serotonin Syndrome vs Neuroleptic Malignant Syndrome in a 12-Year-Old Boy
Sign Up to like & getrecommendations! Published in 2018 at "Pediatric Emergency Care"
DOI: 10.1097/pec.0000000000001477
Abstract: Background Neuroleptic malignant syndrome (NMS) and serotonin syndrome (SS) are serious medical conditions associated with commonly prescribed psychiatric medications. Although the mechanisms differ, they can be clinically difficult to distinguish. We report a case of… read more here.
Keywords: neuroleptic malignant; year old; serotonin syndrome; old boy ... See more keywords
Adverse reaction reports of neuroleptic malignant syndrome induced by atypical antipsychotic agents in the Japanese Adverse Drug Event Report (JADER) database
Sign Up to like & getrecommendations! Published in 2019 at "Psychiatry and Clinical Neurosciences"
DOI: 10.1111/pcn.12793
Abstract: This study evaluates reports on neuroleptic malignant syndrome (NMS) as an adverse event associated with the use of atypical antipsychotic agents (AAA) in Japan. We examined NMS occurrence following monotherapy and combination therapy with AAA… read more here.
Keywords: neuroleptic malignant; antipsychotic agents; atypical antipsychotic; reports neuroleptic ... See more keywords
Neuroleptic malignant syndrome: a concealed diagnosis with multitreatment approach
Sign Up to like & getrecommendations! Published in 2019 at "BMJ Case Reports"
DOI: 10.1136/bcr-2018-225840
Abstract: While neuroleptic malignant syndrome (NMS) is typically characterised by delirium, motor rigidity, fever and dysautonomia, the syndrome is not pathognomonic, and NMS remains a diagnosis of exclusion. Here, we describe the case of a 44-year-old… read more here.
Keywords: neuroleptic malignant; administration; diagnosis; malignant syndrome ... See more keywords
Neuroleptic malignant-like syndrome causing thrombocytopaenia: a rare association
Sign Up to like & getrecommendations! Published in 2018 at "BMJ Case Reports"
DOI: 10.1136/bcr-2018-227089
Abstract: Neuroleptic malignant-like syndrome is a rare but potentially fatal complication of sudden withdrawal of dopaminergic drugs. Clinical features are similar to that of neuroleptic malignant syndrome (NMS) like hyperthermia, autonomic dysfunction, altered sensorium, muscle rigidity;… read more here.
Keywords: neuroleptic malignant; syndrome causing; malignant like; thrombocytopaenia ... See more keywords